Increasing evidence indicates that TLR4/NF-κB signal transduction in the PVN plays a critical role in many animal models of cardiovascular disease, ischemic brain injury, diabetes, atherosclerosis, and other inflammatory diseases [17,18], suggesting the therapeutic potential of targeting this signaling pathway for hypertension. The gene discussed is TLR4; the disease is hypertensive disorder.